Health economics: can we afford an unrestricted use of new biological agents in gastrointestinal oncology?

Carin Uyl - de Groot, G Giaccone

Erasmus School of Health Policy & Management

Research output: Contribution to journal › Article › Academic

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	392-396
Number of pages	5
Journal	Current Opinion in Oncology
Volume	17
Issue number	4
DOIs	https://doi.org/10.1097/01.cco.0000168535.25330.6a
Publication status	Published - 2005

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

10.1097/01.cco.0000168535.25330.6a

http://hdl.handle.net/1765/72616

Cite this

@article{bda39a0824a3498bb87a4512f4d762e3,

title = "Health economics: can we afford an unrestricted use of new biological agents in gastrointestinal oncology?",

author = "{Uyl - de Groot}, Carin and G Giaccone",

year = "2005",

doi = "10.1097/01.cco.0000168535.25330.6a",

language = "Undefined/Unknown",

volume = "17",

pages = "392--396",

journal = "Current Opinion in Oncology",

issn = "1040-8746",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

TY - JOUR

T1 - Health economics: can we afford an unrestricted use of new biological agents in gastrointestinal oncology?

AU - Uyl - de Groot, Carin

AU - Giaccone, G

PY - 2005

Y1 - 2005

U2 - 10.1097/01.cco.0000168535.25330.6a

DO - 10.1097/01.cco.0000168535.25330.6a

M3 - Article

C2 - 15933476

SN - 1040-8746

VL - 17

SP - 392

EP - 396

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

IS - 4

ER -